肺部液体定量雾化器
By introducing oral and nasal exposure systems for large and small animals and lung liquid quantitative nebulizer, InnoStar's inhalation product assessment platform has successfully established a complete set of technologies for inhalation drug delivery, including aerosol particle size determination technology, aerosol sampling technology, aerosol stability and homogeneity determination technology and inhalation drug delivery technology in different animal species with different inhalation formulations.
● One-stop platform for preclinically assessing efficacy, pharmacokinetics and safety of inhaled drugs
● Experienced and technologically-advanced research teams
● Excellent equipment and instruments
● Comprehensive and professional assessment of different programs and formulations
InnoStar's Inhalation Product Assessment Platform can regularly the test particle size and stability and homogeneity of aerosols when the drug is inhaled by animals to ensure that the aerosols produced during the whole inhalation process meet applicable requirements. Moreover, the platform can also monitor the temperature, humidity, differential pressure of the test article exposure chamber, differential pressure of the shielded chamber, oxygen concentration, carbon dioxide concentration and other environmental parameters during the whole exposure test in real time to ensure that the estimated dosage for administration will not be affected by animals' stress reaction or other factors.
Address: 199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, China
Postcode: 201203
Tel: +86-21-60211999
services@innostar.cn
86-021-xxxxxxx
Scan the QR code
Subscription to our Wechat account
Copyright © 2017-2021©中国·手机球探(bet007认证)官方网站-Macau App Station. All Rights Reserved. Created By VPABrand.com
